Stock Information
Revolution Medicines Inc (RVMD)
Ticker Symbol: RVMD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $44,649.51 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -4.80
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -54.06%
Latest News
-
Revolution Medicines (RVMD) Stock Looks Overvalued Even After Its Drug Approval
Sat, Sep 5, 2026 2:13 PM
-
Revolution Medicines (RVMD) Wins FDA Nod While Cancer Study Lands In Leading Journal
Sat, Sep 5, 2026 5:06 AM
-
Revolution Med (RVMD) Priced Rasonque at $39,800 per 30-Day Supply. Can Access Match the Clinical Breakthrough?
Fri, Sep 4, 2026 5:22 PM
-
Revolution Medicines Got Its Breakthrough—What Moves It Next?
Fri, Sep 4, 2026 5:15 PM
-
Revolution Medicines (RVMD) Up 6.6% Since Last Earnings Report: Can It Continue?
Fri, Sep 4, 2026 3:30 PM
-
$100 Invested In Revolution Medicines 5 Years Ago Would Be Worth This Much Today
Fri, Sep 4, 2026 10:30 AM
-
Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
Fri, Sep 4, 2026 9:00 AM
-
Why Are 42% of US Cancer Patients Draining Their Life Savings in Two Years? Bernie Sanders Has a $400,000 Answer
Thu, Sep 3, 2026 2:31 PM
-
Reported Earlier, Revolution Medicines Lung Cancer Drug Shows 42% Response Rate In Early Trial
Thu, Sep 3, 2026 3:49 AM
-
New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer
Wed, Sep 2, 2026 9:50 PM
Key Financials
Financial data not available
